ID: ALA4960900

Max Phase: Preclinical

Molecular Formula: C11H17N3O3

Molecular Weight: 239.28

Molecule Type: Unknown

Representations

Molfile:

Canonical SMILES:

copy

Standard InChI:

copy

Standard InChI Key:

copy

Alternative Forms

1. Parent:

   

   ALA4960900

   ---

Molecule Features

Natural Product: No

Chemical Probe: No

Molecule Type: Unknown

First In Class: No

Chirality: No

Prodrug: No

Oral: No

Parenteral: No

Topical: No

Black Box: No

Availability: No

Activity Summary

Bioactivity Summary	Count
Z score	1
Inhibition	1

Assay Summary	Count
F-Functional	1

Properties

Molecular Weight: 239.28

Molecular Weight (Monoisotopic): 239.1270

AlogP: 0.84

#Rotatable Bonds: 3

Polar Surface Area: 68.46

Molecular Species: NEUTRAL

HBA: 5

HBD: 0

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa:

CX LogP: 0.59

CX LogD: 0.59

Aromatic Rings: 1

Heavy Atoms: 17

QED Weighted: 0.78

Np Likeness Score: -0.71

References

1. Dechering K; Duffey M.  (2022)  .  Replenishing the malaria drug discovery pipeline: Screening and hit evaluation of the MMV Hit Generation Library 1 (HGL1) against asexual blood stage Plasmodium falciparum ,using a nano luciferase reporter read-out,      [PMID:]

Source

Source(1):

• MMV Malaria HGL